Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4725 | 1737 | 40.8 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
298 | 3 | UROLOGY & NEPHROLOGY//PROTEINURIA//NEPHROTIC SYNDROME | 41270 |
524 | 2 | MICROALBUMINURIA//CYSTATIN C//GLOMERULAR FILTRATION RATE | 14999 |
4725 | 1 | GLOMERULOSCLEROSIS//NEPHROL S 151//HYPERLIPIDEMIA | 1737 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLOMERULOSCLEROSIS | authKW | 99232 | 4% | 8% | 75 |
2 | NEPHROL S 151 | address | 73238 | 0% | 83% | 5 |
3 | HYPERLIPIDEMIA | authKW | 70681 | 6% | 4% | 105 |
4 | NEPHROTIC SYNDROME | authKW | 67651 | 6% | 4% | 104 |
5 | STATINS | authKW | 65045 | 9% | 2% | 165 |
6 | ANALBUMINEMIA | authKW | 64560 | 1% | 28% | 13 |
7 | KIDNEY INTERNATIONAL | journal | 60370 | 13% | 2% | 223 |
8 | DYSLIPIDEMIA | authKW | 60339 | 6% | 3% | 102 |
9 | UROLOGY & NEPHROLOGY | WoSSC | 55102 | 52% | 0% | 898 |
10 | APA HAMSTER | authKW | 51125 | 0% | 36% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 55102 | 52% | 0% | 898 |
2 | Transplantation | 1328 | 6% | 0% | 106 |
3 | Peripheral Vascular Diseases | 766 | 7% | 0% | 119 |
4 | Medicine, General & Internal | 738 | 11% | 0% | 191 |
5 | Cardiac & Cardiovascular System | 382 | 7% | 0% | 123 |
6 | Endocrinology & Metabolism | 306 | 6% | 0% | 110 |
7 | Medical Laboratory Technology | 266 | 2% | 0% | 40 |
8 | Medicine, Research & Experimental | 257 | 6% | 0% | 99 |
9 | Nutrition & Dietetics | 101 | 3% | 0% | 46 |
10 | Pathology | 58 | 2% | 0% | 41 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEPHROL S 151 | 73238 | 0% | 83% | 5 |
2 | LIPID LIPOPROT | 49084 | 1% | 31% | 9 |
3 | NEPHROL SECT 111N | 35155 | 0% | 100% | 2 |
4 | NEPHROL | 25596 | 18% | 0% | 305 |
5 | INTERNAL MED RENAL UNIT | 23436 | 0% | 67% | 2 |
6 | NEPHROL HYPERTENS | 17617 | 4% | 1% | 78 |
7 | AFFILIATED HOSP FOSHAN | 17578 | 0% | 100% | 1 |
8 | AGR LIFE SCI AGR | 17578 | 0% | 100% | 1 |
9 | ASTRAZENECA R D | 17578 | 0% | 100% | 1 |
10 | BASE MOL PATHOL HUMAINE | 17578 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KIDNEY INTERNATIONAL | 60370 | 13% | 2% | 223 |
2 | AMERICAN JOURNAL OF KIDNEY DISEASES | 15283 | 5% | 1% | 86 |
3 | NEPHRON | 14886 | 4% | 1% | 64 |
4 | NEPHROLOGY DIALYSIS TRANSPLANTATION | 8785 | 5% | 1% | 79 |
5 | MINERAL AND ELECTROLYTE METABOLISM | 8104 | 1% | 2% | 23 |
6 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 6994 | 3% | 1% | 54 |
7 | CLINICAL AND EXPERIMENTAL NEPHROLOGY | 5451 | 1% | 2% | 18 |
8 | CONTRIBUTIONS TO NEPHROLOGY | 4556 | 1% | 1% | 20 |
9 | CLINICAL NEPHROLOGY | 4314 | 2% | 1% | 35 |
10 | AMERICAN JOURNAL OF NEPHROLOGY | 4218 | 2% | 1% | 28 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLOMERULOSCLEROSIS | 99232 | 4% | 8% | 75 | Search GLOMERULOSCLEROSIS | Search GLOMERULOSCLEROSIS |
2 | HYPERLIPIDEMIA | 70681 | 6% | 4% | 105 | Search HYPERLIPIDEMIA | Search HYPERLIPIDEMIA |
3 | NEPHROTIC SYNDROME | 67651 | 6% | 4% | 104 | Search NEPHROTIC+SYNDROME | Search NEPHROTIC+SYNDROME |
4 | STATINS | 65045 | 9% | 2% | 165 | Search STATINS | Search STATINS |
5 | ANALBUMINEMIA | 64560 | 1% | 28% | 13 | Search ANALBUMINEMIA | Search ANALBUMINEMIA |
6 | DYSLIPIDEMIA | 60339 | 6% | 3% | 102 | Search DYSLIPIDEMIA | Search DYSLIPIDEMIA |
7 | APA HAMSTER | 51125 | 0% | 36% | 8 | Search APA+HAMSTER | Search APA+HAMSTER |
8 | PROTEINURIA | 43800 | 6% | 2% | 106 | Search PROTEINURIA | Search PROTEINURIA |
9 | IMPAIRED EXERCISE CAPACITY | 39548 | 0% | 75% | 3 | Search IMPAIRED+EXERCISE+CAPACITY | Search IMPAIRED+EXERCISE+CAPACITY |
10 | GLOMERULAR ATHEROSCLEROSIS | 35155 | 0% | 100% | 2 | Search GLOMERULAR+ATHEROSCLEROSIS | Search GLOMERULAR+ATHEROSCLEROSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ELISAF, M , MIKHAILIDIS, DP , SIAMOPOULOS, KC , (1996) DYSLIPIDAEMIA IN PATIENTS WITH RENAL DISEASES.JOURNAL OF DRUG DEVELOPMENT AND CLINICAL PRACTICE. VOL. 7. ISSUE 4. P. 331-348 | 114 | 67% | 3 |
2 | PALMER, SC , CRAIG, JC , NAVANEETHAN, SD , TONELLI, M , PELLEGRINI, F , STRIPPOLI, GFM , (2012) BENEFITS AND HARMS OF STATIN THERAPY FOR PERSONS WITH CHRONIC KIDNEY DISEASE A SYSTEMATIC REVIEW AND META-ANALYSIS.ANNALS OF INTERNAL MEDICINE. VOL. 157. ISSUE 4. P. 263 -+ | 55 | 54% | 126 |
3 | SU, XL , ZHANG, L , LV, JC , WANG, JW , HOU, WY , XIE, XF , ZHANG, H , (2016) EFFECT OF STATINS ON KIDNEY DISEASE OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 67. ISSUE 6. P. 881 -892 | 53 | 62% | 3 |
4 | NIKOLIC, D , BANACH, M , NIKFAR, S , SALARI, P , MIKHAILIDIS, DP , TOTH, PP , ABDOLLAHI, M , RAY, KK , PENCINA, MJ , MALYSZKO, J , ET AL (2013) A META-ANALYSIS OF THE ROLE OF STATINS ON RENAL OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE. IS THE DURATION OF THERAPY IMPORTANT?.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 168. ISSUE 6. P. 5437-5447 | 51 | 72% | 25 |
5 | VAZIRI, ND , (2006) DYSLIPIDEMIA OF CHRONIC RENAL FAILURE: THE NATURE, MECHANISMS, AND POTENTIAL CONSEQUENCES.AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. VOL. 290. ISSUE 2. P. F262 -F272 | 54 | 71% | 171 |
6 | TSIMIHODIMOS, V , DOUNOUSI, E , SIAMOPOULOS, KC , (2008) DYSLIPIDEMIA IN CHRONIC KIDNEY DISEASE: AN APPROACH TO PATHOGENESIS AND TREATMENT.AMERICAN JOURNAL OF NEPHROLOGY. VOL. 28. ISSUE 6. P. 958 -973 | 73 | 50% | 51 |
7 | VAZIRI, ND , NORRIS, KC , (2013) REASONS FOR THE LACK OF SALUTARY EFFECTS OF CHOLESTEROL-LOWERING INTERVENTIONS IN END-STAGE RENAL DISEASE POPULATIONS.BLOOD PURIFICATION. VOL. 35. ISSUE 1-3. P. 31-36 | 38 | 83% | 9 |
8 | RYSZ, J , GLUBA-BRZOZKA, A , BANACH, M , WIECEK, A , (2015) SHOULD WE USE STATINS IN ALL PATIENTS WITH CHRONIC KIDNEY DISEASE WITHOUT DIALYSIS THERAPY? THE CURRENT STATE OF KNOWLEDGE.INTERNATIONAL UROLOGY AND NEPHROLOGY. VOL. 47. ISSUE 5. P. 805 -813 | 41 | 67% | 6 |
9 | ATTMAN, PO , SAMUELSSON, O , ALAUPOVIC, P , (1993) LIPOPROTEIN METABOLISM AND RENAL-FAILURE.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 21. ISSUE 6. P. 573-592 | 77 | 56% | 248 |
10 | WHEELER, DC , BERNARD, DB , (1994) LIPID ABNORMALITIES IN THE NEPHROTIC SYNDROME - CAUSES, CONSEQUENCES, AND TREATMENT.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 23. ISSUE 3. P. 331-346 | 68 | 68% | 106 |
Classes with closest relation at Level 1 |